Target intelligence / Profile preview

39S ribosomal protein L17, mitochondrial (MRPL17)

Target
MRPL17
Molecular classification
Ribosomal protein, Structural constituent of ribosome, Mitochondrial ribosomal large subunit protein (39S)
01

Overview

MRPL17 encodes the 39S ribosomal protein L17, a component of the large subunit of the mammalian mitochondrial ribosome[1][5][7]. Unlike cytoplasmic ribosomal proteins, mitochondrial ribosomal proteins are encoded by nuclear genes, translated in the cytosol, and imported into mitochondria for assembly into the mitoribosome. MRPL17 is essential for the structural and functional integrity of the mitochondrial ribosome and for mitochondrial protein synthesis, which is critical for cellular energy production through oxidative phosphorylation[1][2][4][5]. Disruption of MRPL17 or other mitochondrial ribosomal proteins can result in impaired energy metabolism and is associated with various mitochondrial disorders and, in some cases, cancer[4]. Mammalian ribosomal proteins have low sequence conservation with bacterial homologs, underlining unique evolutionary modifications[1][4][6]. There is no redundancy among mitochondrial ribosomal proteins, and loss of function is usually lethal or results in severe disease phenotypes[4]. MRPL17 itself is not a therapeutic target and does not interact directly with drugs, but its function is indispensable for cell survival.

Other names
mammalian mitochondrial ribosomal protein L17MRPL17
02

Biological functions

Mitochondrial protein synthesis (translation within mitochondria)Structural organization of mitochondrial ribosome
03

Disease associations

Mitochondrial disease (general category; some mitochondrial ribosomal proteins associated with cardiomyopathy, sensorineural deafness, diabetes, lactic acidosis, Leigh syndrome, combined oxidative phosphorylation deficiency, and cancer)Cell proliferation and apoptosis (as part of broader ribosomal protein family)

Beyond the preview

Go deeper on 39S ribosomal protein L17, mitochondrial (MRPL17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 39S ribosomal protein L17, mitochondrial (MRPL17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call